Table 1 Patients’ characteristic.
n | % | |||
|---|---|---|---|---|
Gender | ||||
Male | 5 | 50 | ||
Female | 5 | 50 | ||
ECOG Performance Status | ||||
0 | 3 | 30 | ||
1 | 4 | 40 | ||
2 | 3 | 30 | ||
Type of myeloma | ||||
IgG | 5 | 50 | ||
IgD | 1 | 10 | ||
IgA | 1 | 10 | ||
Light chain | 3 | 30 | ||
R-ISS stage at initial diagnosis | ||||
I | 1 | 10 | ||
II | 7 | 70 | ||
III | 2 | 20 | ||
Cytogenetics | ||||
Normal | 7 | 70 | ||
Del 17p | 1 | 10 | ||
1q21 gain | 3 | 30 | ||
Del 13q | 1 | 10 | ||
Serum beta-2 microglobulin level | ||||
<3.5 mg/liter | 3 | 30 | ||
3.5-5.5 mg/liter | 5 | 50 | ||
>5.5 mg/liter | 2 | 20 | ||
Response to Therapy | ||||
sCR | 2 | 20 | ||
CR | 2 | 20 | ||
VGPR | 4 | 40 | ||
PR | 2 | 20 | ||
